Table 3 Fold reduction in biofilm formation of the tested compounds compared to the untreated control.

From: Isolation and characterization of Chitosan from shrimp shell waste and the sustainable preparation of salicylic acid-loaded Chitosan nanoparticles for antibiofilm applications

 

Chitosan-NPs

Salicylic-acid

M1

M2

M3

M4

Candida albicans

4.95e ± 0.029

4.21e ± 0.091

8.31a ± 0.088

7.22b ± 0.042

5.38d ± 0.033

6.42c ± 0.067

Staphylococcus aureus

3.39b ± 0.074

3.32b ± 0.054

3.42b ± 0.023

3.21b ± 0.076

4.69a ± 0.047

2.76c ± 0.032

Escherichia coli

2.75c ± 0.083

2.97c ± 0.025

2.85c ± 0.011

3.9a ± 0.029

3.42b ± 0.067

3.79b ± 0.042

Klebsiella pneumoniae

3.34d ± 0.036

3.22d ± 0.035

3.66c ± 0.089

4.54b ± 0.052

5.56a ± 0.028

4.95b ± 0.017

  1. Different superscript letters indicate significant differences across rows (p < 0.05).
  2. Data are presented as mean ± standard deviation (SD).